Experiential psychotherapy is generally accepted as one of the major families of psychotherapy. One of the main purposes of this introduction to the theme issue is to invite leading proponents and exponents to provide their own answers to the question of how to do experiential psychotherapy, with the emphasis on what would be helpful to students, trainees, and practitioners somewhat familiar with the approach. A second main purpose is to make a case that the very idea of an "experiential family" is a myth. There is no such thing as an "experiential family" of psychotherapies. There are not distinctively common family characteristics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1176/appi.psychotherapy.2007.61.3.231 | DOI Listing |
JMIR Ment Health
January 2025
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States.
Background: Evidence-based digital therapeutics represent a new treatment modality in mental health, potentially providing cost-efficient, accessible means of augmenting existing treatments for chronic mental illnesses. CT-155/BI 3972080 is a prescription digital therapeutic under development as an adjunct to standard of care treatments for patients 18 years of age and older with experiential negative symptoms (ENS) of schizophrenia. Individual components of CT-155/BI 3972080 are designed based on the underlying principles of face-to-face treatment.
View Article and Find Full Text PDFFront Psychol
January 2025
Department for Clinical Psychology and Psychotherapy, Philipps University Marburg, Marburg, Germany.
Background: Several studies identified affect-regulatory qualities of deceptive placebos within negative and positive affect. However, which specific characteristics of an affect-regulatory framing impacts the placebo effect has not yet been subject to empirical investigations. In particular, it is unclear whether placebo- induced expectations of direct emotion inhibition or emotion regulation after emotion induction elicit stronger effects in affect regulation.
View Article and Find Full Text PDFBackground: Understanding variables that influence therapy outcomes can improve the results of interventions and reduce socio-health costs. The current study examined possible predictors and moderators of outcome (age, gender, duration of panic disorder, motivation to change, conscientiousness, and experiential avoidance) in Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT).
Method: Eighty participants with a diagnosis of panic disorder, 56 women and 24 men, with an average age of 38 years, received 12 group sessions of CBT or ACT.
Front Psychiatry
January 2025
School of Fine Arts - Graduate Program in Art Therapy, Maharashtra Institute of Technology, Pune, India.
The field of addiction in its priority to save lives has emphasized harm reduction and medication therapies that have taken precedence over counseling and psychotherapy. The extensive mental health needs, traumatic histories and cognitive challenges of this population call for more availability of all treatments, but also in-depth treatment for the causes of the addiction. The prevalence of trauma is examined with regard to the challenge it presents in treatment for substance use disorder (SUD), and other comorbidities.
View Article and Find Full Text PDFJ Psychopharmacol
January 2025
Division of Clinical Psychological Intervention, Freie Universität Berlin, Berlin, Germany.
Background: Recent clinical trials suggest promising antidepressant effects of psilocybin, despite methodological challenges. While various studies have investigated distinct mechanisms and proposed theoretical opinions, a comprehensive understanding of psilocybin's neurobiological and psychological antidepressant mechanisms is lacking.
Aims: Systematically review potential antidepressant neurobiological and psychological mechanisms of psilocybin.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!